
A Full Cycle
of Mental Wellness
From Research to Remedy
MINDCURE identifies, innovates, and commercializes new methods to promote Mental Wealth™. Psychedelics can heal a world in pain and MINDCURE is leading the way.
How We Elevate Mental Wealth
MINDCURE isn’t your typical pharma company.
We’re revolutionizing mental health treatment options by combining these intimately related spheres:

Our Technology
Meet our cutting-edge digital therapeutics platform optimizing healing for mental health clinicians and patients

Our Research
Discover how we identify opportunities and develop treatment pathways
Our
Technology
Digital Therapeutics
Making Mental Wealth Accessible
iSTRYM is a first-of-its-kind software application that optimizes the healing journey for both patients and clinicians — before, during, and after therapy sessions. By bringing together a variety of healing solutions, such as convenient user dashboards, guided mindfulness practices, intelligent data analysis, and more, iSTRYM optimizes therapy.

Supporting
Clinicians
Access a robust repository of treatment protocols and care packages
Individualize care with digitized, data-driven analytics
Monitor client status before, during, and after sessions for deeper insights that don’t interrupt care

Empowering Individuals
Own your mental wellness journey with automated support, personalized to your custom care needs and preferences
Explore guided practices to elevate your mindset



Our Research
MINDCURE’s research team is constantly uncovering opportunities to promote healing. We develop psychedelic treatment protocols and synthesize compounds for commercial use in clinical studies that show therapeutic potential.
The Desire Project
Using MDMA-Assisted Psychotherapy to Help Women Overcome Lack of Desire
Hypoactive Sexual Desire Disorder (HSDD) is a common female sexual disorder characterized by persistent low sexual desire and emotional distress that are not attributable to an existing medical condition or relationship issue.
In the U.S. alone, HSDD affects an estimated 9.5 million premenopausal women.
Learn more about the research MINDCURE is doing to address this under researched and under treated condition.
The Ibogaine Project
Sustainable supply of synthesized ibogaine
MINDCURE is manufacturing synthetic ibogaine in order to provide researchers and clinicians with the resources they need to promote healing.
Indications include addiction, migraines, cluster headaches, neuropathic pain, treatment-resistant mood disorders, and more.
There is a growing need for a sustainable and reliable supply of ibogaine.